Jim Cramer’s exclusive with a biotech up nearly 40- percent this year. Can it keep roaring? » Subscribe to CNBC: » Watch more …
source CNBC
United Therapeutics CEO: A Race To Save Her Daughter | Mad Money | CNBC
previous post
Jim Cramer’s exclusive with a biotech up nearly 40- percent this year. Can it keep roaring? » Subscribe to CNBC: » Watch more …
source CNBC
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More